Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in Germany, US, Singapore, and China. Contact: [email protected]
Investor insights
Funding rounds participated in
$100M sweet spot round size
Investor type
Basic info
Industry
Sectors
Date founded
2018
Funding rounds raised
Total raised
$100M
from 3 investors over 1 rounds
Singleron Biotechnologies raised $100M on December 8, 2021
Investors: Firstred Capital, Lake Bleu Capital and + 7 Other investors